Evidence map›Paper›PMID 33888685›Full record

ArticleTranslational psychiatry2021

BDNF haploinsufficiency induces behavioral endophenotypes of schizophrenia in male mice that are rescued by enriched environment.

Mahmoud Harb, Justina Jagusch, Archana Durairaja, Thomas Endres, Volkmar Leßmann, Markus Fendt

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 20 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Mahmoud HarbInstitute for Pharmacology and Toxicology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Justina JaguschInstitute for Pharmacology and Toxicology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Archana DurairajaInstitute for Pharmacology and Toxicology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Thomas EndresInstitute of Physiology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany.
Volkmar LeßmannInstitute of Physiology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany. volkmar.lessmann@med.ovgu.de.
Markus FendtInstitute for Pharmacology and Toxicology, Otto-von-Guericke University Magdeburg, Magdeburg, Germany. markus.fendt@med.ovgu.de.ORCID http://orcid.org/0000-0002-3451-1226
Otto-von-Guericke-Universität Magdeburg · DECenter for Behavioral Brain Sciences · DE

Funding

Deutsche Forschungsgemeinschaft (German Research Foundation) SFB779Deutsche Forschungsgemeinschaft (German Research Foundation) SFB779/B13
6 · The paper itself

Abstract

Brain-derived neurotrophic factor (BDNF) is implicated in a number of processes that are crucial for healthy functioning of the brain. Schizophrenia is associated with low BDNF levels in the brain and blood, however, not much is known about BDNF's role in the different symptoms of schizophrenia. Here, we used BDNF-haploinsufficient (BDNF

Indexed as

Brain-Derived Neurotrophic FactorSchizophreniaAnimalsEndophenotypesHaploinsufficiencyMaleMiceMice, Inbred C57BLReflex, StartleBrain-Derived Neurotrophic Factor

Identifiers

PMID33888685
PMCPMC8062437
OpenAlexW3152672077

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.